Champions Oncology Stock Price

-0.03 (-0.3%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 13,670
Bid Price 9.48
Ask Price 10.00
News -
Day High 10.06


52 Week Range


Day Low 9.94
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Champions Oncology Inc CSBR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.03 -0.3% 9.97 20:00:00
Open Price Low Price High Price Close Price Prev Close
10.06 9.94 10.06 9.97 10.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
120 13,670 $ 10.01 $ 136,812 - 8.30 - 14.68
Last Trade Time Type Quantity Stock Price Currency
16:00:00 26 $ 10.00 USD


Draw Mode:

Champions Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 133.82M 13.42M 6.84M $ 41.04M $ 106.70k 0.02 504.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 57.60%

more financials information »

Champions Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CSBR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week10.1110.22999.9410.117,138-0.14-1.38%
1 Month10.3610.609.8710.148,636-0.39-3.76%
3 Months10.5111.009.2310.2229,137-0.54-5.14%
6 Months11.3111.538.459.8835,578-1.34-11.85%
1 Year9.1314.688.3010.6134,7410.849.2%
3 Years12.7715.454.029.3043,260-2.80-21.93%
5 Years1.6617.901.567.9860,4918.31500.6%

Champions Oncology Description

Champions Oncology Inc is a US-based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies.
Your Recent History
Champions ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211024 12:29:38